SOARIAN

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2015-08-12 for SOARIAN manufactured by Siemens.

Event Text Entries

[23424761] There was treatment for end stage heart failure that included potassium sparing diuretics, potassium supplements, and other medications listed on heart failure therapy guidelines. Initially, there was syncope with ventricular tachycardia while the potassium was less than normal. It was not until 24 hours after a potassium test result was completed that was 6 meq/l ( up from 5 meq/l one day earlier) that anyone noticed this life threatening metabolic problem. The treatment and medication adjustments resulted in a prolonged hospitalization. The failure of the device to warn of new results renders the ehr mdds not unlike a heart monitor, that requires chronic vigilance to avoid missing a critical arrhythmia. The ehr mdds generally has zero vigilance.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5055473
MDR Report Key5011248
Date Received2015-08-12
Date of Report2015-08-12
Date of Event2015-08-08
Device Manufacturer Date2013-10-01
Date Added to Maude2015-08-18
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameSOARIAN
Generic NameMDDS/EHR
Product CodeNSX
Date Received2015-08-12
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS
Manufacturer AddressMALVERN PA 19355 US 19355


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Life Threatening; 3. Required No Informationntervention 2015-08-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.